1. Hua Fang*, Weihua Wu, Zhijun Wu.miR-382-3p downregulation contributes to the carcinogenesis of lung adenocarcinoma by promoting AKT SUMOylation and phosphorylation..EXPERIMENTAL AND THERAPEUTIC MEDICINE .2022.24(1).440-449.SCI |
2. Hua Fang, Yutao Liu, Yang Jiang, Yaping Wei, Han Liu, Yueqing Gong, Guangyu An*.Extracellular vesicle‑delivered miR‑505‑5p, as a diagnostic biomarker of early lung adenocarcinoma, inhibits cell apoptosis by targeting TP53AIP1.International Journal of Oncology.2019.54(5).1821-1832.SCI |
3. Hua Fang, Huimin Liu, Weihua Wu, Han Liu, Yong Pan, Wenjun Li*.Upregulation of long nonc oding RNA CCAT1-L promotes epithelial–mesenchymal transition in gastric adenocarcinoma.OncoTargets and Therapy.2018.2018(11).5647-5655.SCI |
4. Yi Hu#, Jianhong Lin#, Hua Fang#, Jing Fang, Chen Li, Wei chen, Shuang Liu, Sarah Ondrejka, Zihua Gong, Frederic Reu, Jaroslaw Maciejewski, Qing Yi, Jianjun Zhao*.Targeting the MALAT1/PARP 1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma.Leukemia.2018.32(10).2250 -2262.SCI |
5. 方桦,王兴元*,冯奉仪,王金万.不同治疗方法对结直肠癌肝转移患者预后的影响.中华肿瘤杂志.2010.2010(1).67-70.核心期刊 |
6. 方桦,王兴元,王金万,张弘纲,冯奉仪,石远凯*.300例结直肠癌肝转移患者的临床预后分析.中华肿瘤杂志.2009.2009(3).220-222.核心期刊 |